Publications in collaboration with researchers from Institute Catalá Oncología (9)

2016

  1. Conditionally Replicative Adenoviruses-Clinical Trials

    Adenoviral Vectors for Gene Therapy: Second Edition (Elsevier Inc.), pp. 335-348

2009

  1. Oncolytic adenovirus retargeted to Delta-EGFR induces selective antiglioma activity

    Cancer Gene Therapy, Vol. 16, Núm. 3, pp. 256-265

2008

  1. E2F1 in gliomas: A paradigm of oncogene addiction

    Cancer Letters, Vol. 263, Núm. 2, pp. 157-163

2007

  1. Combination of the oncolytic adenovirus ICOVIR-5 with chemotherapy provides enhanced anti-glioma effect in vivo

    Cancer Gene Therapy, Vol. 14, Núm. 8, pp. 756-761

  2. ICOVIR-5 shows E2F1 addiction and potent antiglioma effect in vivo

    Cancer Research, Vol. 67, Núm. 17, pp. 8255-8263

2006

  1. Delta-24 increases the expression and activity of topoisomerase I and enhances the antiglioma effect of irinotecan

    Clinical Cancer Research, Vol. 12, Núm. 2, pp. 556-562

2005

  1. Comparative effect of oncolytic adenoviruses with E1A or E1B-55 kDa deletions in malignant gliomas

    Neoplasia, Vol. 7, Núm. 1, pp. 48-56

  2. Downmodulation of E1A protein expression as a novel strategy to design cancer-selective adenoviruses

    Neoplasia, Vol. 7, Núm. 8, pp. 723-729

2004

  1. A novel E1A-E1B mutant adenovirus induces glioma regression in vivo

    Oncogene, Vol. 23, Núm. 10, pp. 1821-1828